Skip to main content
    H

    HCA Healthcare, Inc. (HCA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $511.78
    +12.73 (+2.55%)

    Market Cap: $104.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HCA Healthcare, Inc. (HCA) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    HCA Healthcare (HCA) trades at 17.1x trailing earnings and 1.4x sales. Its P/E of 17.1x is above its 5-year median of 15.0x. Its forward P/E is 15.9x. The median P/E across 10 similar companies is 19.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 7.5% higher over the next year. Its free cash flow yield is 5.4%.

    MultipleValue
    P/E (trailing)17.1x
    Forward P/E15.9x
    Price to sales1.4x
    EV/EBITDA10.0x
    Price to FCF18.4x
    EV/FCF26.7x
    PEG1.5
    FCF yield5.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 20.4% above 14.2x and its P/S is 27.3% above 1.1x.

    MultipleCurrent5-year median10-year median
    P/E17.1x15.0x14.2x
    P/S1.4x1.2x1.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 10.8x in 2016 to 16.6x in 2020.

    Year endPriceP/EP/SP/B
    2025$466.8616.5x1.5xN/A
    2024$300.1513.7x1.1x138.1x
    2023$270.6814.2x1.1x69.2x
    2022$239.9614.2x1.2xN/A
    2021$256.9214.7x1.4x54.4x
    2020$164.4616.6x1.1x19.6x
    2019$147.8114.1x1.0xN/A
    2018$124.4512.7x0.9xN/A
    2017$87.8412.9x0.7xN/A
    2016$74.0210.8x0.7xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HCA

    What is HCA's forward P/E ratio?

    HCA Healthcare has a forward P/E ratio of 15.9x.

    Is HCA stock overvalued?

    GNG's valuation label for HCA is Fairly valued. Its P/E of 17.1x compares with a median of 19.9x across 10 similar companies.

    What is HCA's price to sales ratio?

    HCA Healthcare has a price to sales ratio of 1.4x.

    What is HCA Healthcare's average P/E ratio over 5 years?

    HCA Healthcare's median P/E over the last 5 years is 15.0x, from 60 month-end values through Oct 2026.

    What is HCA's PEG ratio?

    HCA Healthcare has a PEG ratio of 1.5.